Antiarrhythmic Drugs Market
According to Intent Market Research, the Antiarrhythmic Drugs Market is expected to grow from USD 1.7 billion in 2023 at a CAGR of 8.3% to touch USD 2.9 billion by 2030. The Antiarrhythmic Drugs Market is dominated by key players such as, Novartis, Pfizer, Sanofi, Upsher-Smith Laboratories, and Mayne Pharma.